Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections
José Manuel Quesada‐Gómez, Marta Entrenas Castillo, Roger Bouillon
The Journal of Steroid Biochemistry and Molecular Biology (2020) Vol. 202, pp. 105719-105719
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
Marta Entrenas Castillo, Luis Manuel Entrenas Costa, José Manuel Vaquero Barrios, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2020) Vol. 203, pp. 105751-105751
Open Access | Times Cited: 698
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
Eugene Merzon, Dmitry Tworowski, Alessandro Gorohovski, et al.
FEBS Journal (2020) Vol. 287, Iss. 17, pp. 3693-3702
Open Access | Times Cited: 407
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Sonia Villapol
Translational research (2020) Vol. 226, pp. 57-69
Open Access | Times Cited: 338
Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
Joseph Mercola, William B. Grant, Carol L. Wagner
Nutrients (2020) Vol. 12, Iss. 11, pp. 3361-3361
Open Access | Times Cited: 261
The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis
Aya Bassatne, Maya Basbous, Marlene Chakhtoura, et al.
Metabolism (2021) Vol. 119, pp. 154753-154753
Open Access | Times Cited: 202
COVID-19 Impact on Public Health, Environment, Human Psychology, Global Socioeconomy, and Education
Youssef Miyah, Mohammed Benjellοun, Sanae Lairini, et al.
The Scientific World JOURNAL (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 153
A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency
Linda Benskin
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 152
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
Iacopo Chiodini, Davide Gatti, Davide Soranna, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 152
Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy
Aurelia Magdalena Pisoschi, Aneta Pop, Florin Iordache, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114175-114175
Open Access | Times Cited: 77
Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress
Guilherme Renke, Bernardo Starling-Soares, Thomaz Baesso, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 769-769
Open Access | Times Cited: 70
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
Juan F. Alcalá‐Díaz, Laura Limia Pérez, Ricardo Gómez‐Huelgas, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1760-1760
Open Access | Times Cited: 98
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy
Irene Campi, Luigi Gennari, Daniela Merlotti, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Calcifediol Treatment and COVID-19–Related Outcomes
Xavier Nogués, Diana Ovejero, Marta Pineda‐Moncusí, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e4017-e4027
Open Access | Times Cited: 89
Vitamin D and COVID-19: evidence and recommendations for supplementation
George E. Griffin, Martin Hewison, Julian M. Hopkin, et al.
Royal Society Open Science (2020) Vol. 7, Iss. 12, pp. 201912-201912
Open Access | Times Cited: 78
COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis
Lorenz Borsche, Bernd Glauner, Julian von Mendel
Nutrients (2021) Vol. 13, Iss. 10, pp. 3596-3596
Open Access | Times Cited: 76
Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study
Sandro Giannini, Giovanni Passeri, Giovanni Tripepi, et al.
Nutrients (2021) Vol. 13, Iss. 1, pp. 219-219
Open Access | Times Cited: 72
Beware of Steroid-Induced Avascular Necrosis of the Femoral Head in the Treatment of COVID-19—Experience and Lessons from the SARS Epidemic
Shenqi Zhang, Chengbin Wang, Lei Shi, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 983-995
Open Access | Times Cited: 70
Vitamin D and COVID‐19: Role of ACE2, age, gender, and ethnicity
Bruk Getachew, Yousef Tizabi
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5285-5294
Open Access | Times Cited: 63
The mechanism of multiple organ dysfunction syndrome in patients with COVID‐19
Wenbin Zhao, Hanmeng Li, Jianghua Li, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1886-1892
Open Access | Times Cited: 51
Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients—Randomized Controlled Trial
Josipa Domazet Bugarin, Svjetlana Došenović, Darko Ilić, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1234-1234
Open Access | Times Cited: 28
Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic?
Hermann Brenner, Bernd Holleczek, Ben Schöttker
Nutrients (2020) Vol. 12, Iss. 8, pp. 2488-2488
Open Access | Times Cited: 64
Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study
Eugene Merzon, Dmitry Tworowski, Alessandro Gorohovski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 51
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients
Carlos Loucera, María Peña-Chilet, Marina Esteban‐Medina, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 50
Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes
Shariq Qayyum, Taj Mohammad, Radomir M. Slominski, et al.
AJP Endocrinology and Metabolism (2021) Vol. 321, Iss. 2, pp. E246-E251
Open Access | Times Cited: 47
Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
Laurence Orchard, Matthew Baldry, Myra Nasim-Mohi, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 6, pp. 1155-1163
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top